HIGHTIDE-B expands share base by 17.28%, raises HK$225.05 million via share placement at HK$2.28
Bulletin Express
Aug 07
HighTide Therapeutics, Inc. (HIGHTIDE-B) disclosed that it has issued 98.71 million new ordinary shares on 7 August 2026 under a placing agreement signed on 31 July 2026. The shares were placed at HK$2.28 each, implying gross proceeds of approximately HK$225.05 million.
The new issuance enlarges the company’s share capital by 17.28%, lifting the outstanding share count from 571.33 million to 670.04 million shares. No treasury shares were created or cancelled, and there were no share repurchases or redemptions during the period.
The board confirmed that the placement complied with all relevant Hong Kong Stock Exchange listing rules and regulatory requirements, and that full consideration for the new shares has been received.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.